Several brokerages have updated their recommendations and price targets on shares of Health Insurance Innovations (NASDAQ: HIIQ) in the last few weeks:

  • 10/17/2017 – Health Insurance Innovations had its “buy” rating reaffirmed by analysts at Northland Securities. They now have a $37.00 price target on the stock.
  • 10/17/2017 – Health Insurance Innovations was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “strong-buy” rating. They now have a $24.00 price target on the stock. According to Zacks, “Health Insurance Innovations, Inc. operates as a developer and administrator of web-based individual health insurance plans and ancillary products. Its product portfolio consists of short-term medical plans, accident, sickness & hospital medical plans, ancillary insurance, life insurance, lifestyle and discount services. Health Insurance Innovations, Inc. is based in Tampa, Florida. “
  • 10/16/2017 – Health Insurance Innovations had its “buy” rating reaffirmed by analysts at Canaccord Genuity. They now have a $39.00 price target on the stock. They wrote, “Date and time of first dissemination: October 16, 2017, 09:40 ET Date and time of production: October 16, 2017, 09:40 ET Target Price / Valuation Methodology: Health Insurance Innovations – HIIQ Our $39 PT is based on an 12.6x target multiple on our 2018 adj. EBITDA estimate. Our target multiple is a 25% discount to a peer group of non-provider health and insurance related technology companies.””
  • 10/11/2017 – Health Insurance Innovations was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Health Insurance Innovations, Inc. operates as a developer and administrator of web-based individual health insurance plans and ancillary products. Its product portfolio consists of short-term medical plans, accident, sickness & hospital medical plans, ancillary insurance, life insurance, lifestyle and discount services. Health Insurance Innovations, Inc. is based in Tampa, Florida. “
  • 10/2/2017 – Health Insurance Innovations was upgraded by analysts at ValuEngine from a “buy” rating to a “strong-buy” rating.
  • 9/28/2017 – Health Insurance Innovations was downgraded by analysts at TheStreet from a “b-” rating to a “c” rating.
  • 9/25/2017 – Health Insurance Innovations had its “buy” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $38.00 price target on the stock. They wrote, “This morning, HIIQ filed an 8-K which indicates, in our opinion, an improving regulatory outlook.””
  • 9/13/2017 – Health Insurance Innovations had its “buy” rating reaffirmed by analysts at Canaccord Genuity. They now have a $39.00 price target on the stock.
  • 9/12/2017 – Health Insurance Innovations had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $38.00 price target on the stock.
  • 9/1/2017 – Health Insurance Innovations had its “buy” rating reaffirmed by analysts at Canaccord Genuity. They now have a $39.00 price target on the stock.
  • 9/1/2017 – Health Insurance Innovations was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating.
  • 9/1/2017 – Health Insurance Innovations had its “buy” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $38.00 price target on the stock.

Shares of Health Insurance Innovations, Inc. (NASDAQ:HIIQ) traded down 4.40% during trading on Thursday, hitting $21.75. 838,829 shares of the stock traded hands. The stock has a market cap of $271.20 million, a PE ratio of 17.60 and a beta of 0.51. The firm’s 50-day moving average price is $22.09 and its 200-day moving average price is $23.28. Health Insurance Innovations, Inc. has a 12 month low of $4.00 and a 12 month high of $37.38.

Health Insurance Innovations (NASDAQ:HIIQ) last issued its quarterly earnings data on Wednesday, August 2nd. The financial services provider reported $0.46 EPS for the quarter, topping analysts’ consensus estimates of $0.33 by $0.13. Health Insurance Innovations had a net margin of 5.56% and a return on equity of 22.89%. The business had revenue of $61.80 million during the quarter, compared to analysts’ expectations of $53.69 million. Health Insurance Innovations’s revenue was up 38.9% compared to the same quarter last year. Analysts anticipate that Health Insurance Innovations, Inc. will post $1.57 EPS for the current year.

In related news, insider Sheldon Wang sold 4,530 shares of Health Insurance Innovations stock in a transaction dated Thursday, September 7th. The shares were sold at an average price of $32.73, for a total transaction of $148,266.90. Following the completion of the transaction, the insider now directly owns 224,894 shares of the company’s stock, valued at approximately $7,360,780.62. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Bruce Telkamp sold 15,000 shares of Health Insurance Innovations stock in a transaction dated Monday, July 24th. The stock was sold at an average price of $27.76, for a total transaction of $416,400.00. Following the transaction, the chief executive officer now directly owns 74,001 shares of the company’s stock, valued at $2,054,267.76. The disclosure for this sale can be found here. Insiders sold a total of 140,077 shares of company stock valued at $4,159,158 over the last three months. Corporate insiders own 30.00% of the company’s stock.

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

Receive News & Stock Ratings for Health Insurance Innovations Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc and related stocks with our FREE daily email newsletter.